1. Home
  2. SID vs SRPT Comparison

SID vs SRPT Comparison

Compare SID & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia Siderurgica Nacional S.A.

SID

Companhia Siderurgica Nacional S.A.

HOLD

Current Price

$1.75

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$21.83

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SID
SRPT
Founded
1941
1980
Country
Brazil
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
1997
1997

Fundamental Metrics

Financial Performance
Metric
SID
SRPT
Price
$1.75
$21.83
Analyst Decision
Strong Sell
Hold
Analyst Count
1
29
Target Price
$1.30
$26.23
AVG Volume (30 Days)
2.2M
3.7M
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,522,708,358.00
$2,413,715,000.00
Revenue This Year
$4.33
$13.83
Revenue Next Year
$0.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.02
47.15
52 Week Low
$1.24
$10.42
52 Week High
$1.93
$129.84

Technical Indicators

Market Signals
Indicator
SID
SRPT
Relative Strength Index (RSI) 57.52 55.82
Support Level $1.46 $20.76
Resistance Level $1.84 $22.85
Average True Range (ATR) 0.07 1.20
MACD 0.02 0.20
Stochastic Oscillator 72.86 70.96

Price Performance

Historical Comparison
SID
SRPT

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: